by Orphagen Pharma | Sep 1, 2019 | News
Orphagen Pharmaceuticals, a privately-held pharmaceutical company, announced today that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has awarded the company $1.8 million under the Small Business Innovation Research (SBIR)...
by Orphagen Pharma | Jun 1, 2018 | News
San Diego, June 1, 2018 – Orphagen Pharmaceuticals, a privately held pharmaceutical company, announced today that it has entered into a collaborative agreement with the pharmaceutical division of Japan Tobacco Inc. (JT) to discover, develop and commercialize drugs...
by Orphagen Pharma | Jun 1, 2018 | News
San Diego, June 1, 2018 – Orphagen Pharmaceuticals, a privately held pharmaceutical company, announced today that it has been awarded US patent 9,657,053 for the use of small molecule ligands to inhibit retinoid-related orphan receptor gamma (RORγ). The patent...
by Orphagen Pharma | Jan 11, 2016 | News
Orphagen Pharmaceuticals, a privately-held emerging pharmaceutical company, described for the first time properties of small molecule antagonists to ROR-beta, an orphan nuclear receptor, at the Keystone Symposium on Nuclear Receptors taking place January 10-14 at...
